Farzin Haque
Stock Analyst at Jefferies
(2.85)
# 1,608
Out of 5,124 analysts
4
Total ratings
50%
Success rate
91.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $4.23 | +112.77% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $8.59 | +16.41% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $1.21 | +726.45% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $47.07 | -44.76% | 1 | Nov 10, 2023 |
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $4.23
Upside: +112.77%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $8.59
Upside: +16.41%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $47.07
Upside: -44.76%